Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers
Open Access
- 1 February 2002
- Vol. 57 (2) , 146-151
- https://doi.org/10.1136/thorax.57.2.146
Abstract
Background: Protease activated receptor-2 (PAR-2) is a transmembrane G protein coupled receptor preferentially activated by trypsin and tryptase. The protease activated receptors play an important role in most components of injury responses including cell proliferation, migration, matrix remodelling, and inflammation. Cigarette smoking causes an inflammatory process in the central airways, peripheral airways, lung parenchyma, and adventitia of pulmonary arteries. Methods: To quantify the expression of PAR-2 in the central airways of smokers and non-smokers, surgical specimens obtained from 30 subjects undergoing lung resection for localised pulmonary lesions (24 with a history of cigarette smoking and six non-smoking control subjects) were examined. Central airways were immunostained with an antiserum specific for PAR-2 and PAR-2 expression was quantified using light microscopy and image analysis. Results: PAR-2 expression was found in bronchial smooth muscle, epithelium, glands, and in the endothelium and smooth muscle of bronchial vessels. PAR-2 expression was similar in the central airways of smokers and non-smokers. When smokers were divided according to the presence of symptoms of chronic bronchitis and chronic airflow limitation, PAR-2 expression was increased in smooth muscle (median 3.8 (interquartile range 2.9–5.8) and 1.4 (1.07–3.4) respectively); glands (33.3 (18.2–43.8) and 16.2 (11.5–22.2), respectively); and bronchial vessels (54.2 (48.7–56.8) and 40.0 (36–40.4), respectively) of smokers with symptoms of chronic bronchitis with normal lung function compared with smokers with chronic airflow limitation (COPD), but the increase was statistically significant (p<0.005) only for bronchial vessels. Conclusions: PAR-2 is present in bronchial smooth muscle, glands, and bronchial vessels of both smokers and non-smokers. An increased expression of PAR-2 was found in bronchial vessels of patients with bronchitis compared with those with COPD.Keywords
This publication has 32 references indexed in Scilit:
- Proteinase-activated receptor-2–mediated matrix metalloproteinase-9 release from airway epithelial cellsJournal of Allergy and Clinical Immunology, 2000
- Activation of Protease-Activated Receptor-2 (PAR-2) Triggers Mucin Secretion in the Rat Sublingual GlandBiochemical and Biophysical Research Communications, 2000
- Protease-activated receptors: sentries for inflammation?Trends in Pharmacological Sciences, 2000
- Modulation of airway smooth muscle tone by protease activated receptor‐1,‐2,‐3 and ‐4 in trachea isolated from influenza A virus‐infected miceBritish Journal of Pharmacology, 2000
- Protease-activated receptors: PAR4 and counting: how long is the course?Trends in Pharmacological Sciences, 1999
- Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat pawBritish Journal of Pharmacology, 1999
- Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpawBritish Journal of Pharmacology, 1998
- Protease activated receptors modulate aortic vascular toneInternational Journal of Cardiology, 1996
- Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscleCanadian Journal of Physiology and Pharmacology, 1995
- Molecular Cloning and Functional Expression of the Gene Encoding the Human Proteinase‐Activated Receptor 2European Journal of Biochemistry, 1995